41 investors have funded 12 Life Sciences companies head-officed in Kfar Saba, across 63 rounds (Dec 2004 – Jul 2024). They are ranked by how many Kfar Saba companies in this market they have actually backed.
"In Kfar Saba" describes the companies, not the investor: most of the money in any city comes from somewhere else, and the Where the money comes from section below shows exactly where it came from here.
Ranked by companies backed in this market and city, then by round count. "Led" counts rounds recorded with this investor as lead.
| # | Investor | Based in | Stages here | Companies | Rounds | Led | Latest | Portfolio total |
|---|---|---|---|---|---|---|---|---|
| 1 | Elron Ventures | Tel Aviv, Israel | Series CSeries ASeries B | 2 | 6 | 2 | Jan 2018 | 44 |
| 2 | Peregrine Ventures | Or Yehuda, Israel | Series ASeries BSeries C | 2 | 5 | — | Jan 2018 | 22 |
| 3 | Triventures | Herzliya, Israel | Series BSeries A | 2 | 2 | 2 | Oct 2017 | 34 |
| 4 | Johnson & Johnson Innovation – JJDC | New Brunswick, United States | Series BSeries C | 1 | 3 | 2 | Jan 2018 | 120 |
| 5 | Accelmed Ventures | Tel Aviv, Israel | Series ASeries B | 1 | 3 | 2 | Jan 2016 | 8 |
| 6 | Access Medical Ventures | Tel Aviv, Israel | Series ASeries B | 1 | 3 | 2 | Jan 2016 | 2 |
| 7 | Sofinnova Partners | Paris, France | SeedSeries A | 1 | 2 | 2 | Jul 2024 | 149 |
| 8 | aMoon | Ra'anana, Israel | Series C | 1 | 2 | 2 | Jan 2018 | 50 |
| 9 | Accelmed | Miami, United States | Series A | 1 | 2 | — | Mar 2012 | 19 |
| 10 | SCP Vitalife | Malvern, United States | Series A | 1 | 2 | — | Nov 2013 | 14 |
| 11 | Maayan Ventures | Tel Aviv, Israel | Seed | 1 | 2 | — | Jul 2006 | 8 |
| 12 | Bioventus | Durham, United States | Series CSeries D | 1 | 2 | 1 | Jul 2020 | 3 |
| 13 | Morningside | Series B | 1 | 1 | 1 | Apr 2009 | 171 | |
| 14 | Deerfield | New York City, United States | Series C | 1 | 1 | 1 | Feb 2019 | 182 |
| 15 | European Union | Belgium | Series A | 1 | 1 | — | Jul 2024 | 195 |
| 16 | Pontifax | Herzliya, Israel | Series B | 1 | 1 | — | Oct 2017 | 74 |
| 17 | Genesis Partners | Herzliya, Israel | Series A | 1 | 1 | — | Nov 2013 | 44 |
| 18 | Medtronic | Minneapolis, United States | Series E+ | 1 | 1 | 1 | Jul 2022 | 56 |
| 19 | Boston Scientific | Marlborough, United States | Series A | 1 | 1 | — | Nov 2013 | 44 |
| 20 | GF Securities | Guangzhou, China | Series B | 1 | 1 | — | Oct 2017 | 58 |
| 21 | Infinity Group | Tel Aviv, Israel | Seed | 1 | 1 | — | Jul 2006 | 32 |
| 22 | Quark Venture | Vancouver, Canada | Series B | 1 | 1 | 1 | Oct 2017 | 25 |
| 23 | Docor | Tel Aviv, Israel | Series A | 1 | 1 | — | Sep 2017 | 18 |
| 24 | Clal Biotechnology Industries | Tel Aviv, Israel | Series A | 1 | 1 | — | Sep 2017 | 16 |
| 25 | Genesis Capital | Atlanta, United States | Series A | 1 | 1 | — | Jun 2009 | 19 |
| 26 | BioStar Capital | Charlevoix, United States | Series B | 1 | 1 | — | Oct 2017 | 13 |
| 27 | Ofer-Hi Tech | Waimes, Belgium | Series B | 1 | 1 | 1 | Feb 2009 | 15 |
| 28 | Rafael Development Corporation | Tel Aviv, Israel | Series A | 1 | 1 | — | Oct 2013 | 13 |
| 29 | Planven Investments | Zurich, Switzerland | Series B | 1 | 1 | — | Oct 2017 | 7 |
| 30 | Millennium Materials Technologies Fund | Tel Aviv, Israel | Series B | 1 | 1 | 1 | Feb 2009 | 6 |
| 31 | Aging2.0 | San Francisco, United States | Seed | 1 | 1 | — | Jul 2016 | 8 |
| 32 | Incentive Incubator | Or Yehuda, Israel | Seed | 1 | 1 | — | Jun 2006 | 7 |
| 33 | Arancia | Guadalajara, Mexico | Series B | 1 | 1 | — | Feb 2009 | 5 |
| 34 | AmiTechnion | Haifa, Israel | Series A | 1 | 1 | — | Sep 2017 | 5 |
| 35 | Ganot Capital | Hollywood, United States | Series A | 1 | 1 | — | Oct 2013 | 3 |
| 36 | Corundum Open Innovation | Minato City, Japan | Series B | 1 | 1 | — | Oct 2017 | 2 |
| 37 | Longtech Ventures | Suzhou, China | Series A | 1 | 1 | — | Nov 2013 | 2 |
| 38 | Frutarom | Haifa, Israel | Post-IPO | 1 | 1 | — | Aug 2017 | 1 |
| 39 | Galam | Pardes Hanna Karkur, Israel | Series B | 1 | 1 | 1 | Feb 2009 | 1 |
| 40 | Partners500 | Modi in Maccabim Re ut, Israel | Seed | 1 | 1 | — | Jul 2006 | 1 |
| 41 | TMC Innovation | Houston, United States | Seed | 1 | 1 | — | Sep 2014 | 1 |
Head office of the investors on this page.
Rounds by stage — where in a company's life this money arrives.
Total disclosed size of each round, not one investor's share.
How active this market has been.
Life Sciences companies head-officed in Kfar Saba that took money from these investors.
| Company | Backers | Rounds | Disclosed | Latest round |
|---|---|---|---|---|
| CathWorks cath.works |
9 | 9 | $215.6M | Series E+ Jul 2022 |
| CartiHeal cartiheal.com |
7 | 21 | $220.7M | Series D Jul 2020 |
| Sensible Medical sensible-medical.com |
5 | 6 | $94M | Series A Nov 2013 |
| Enzymotec enzymotec.com |
5 | 5 | $56.9M | Post-IPO Aug 2017 |
| Colospan colospan.com |
4 | 4 | $32M | Series A Sep 2017 |
| Kyma kyma-med.com |
3 | 3 | $30M | Series A Oct 2013 |
| NLT Spine nlt-spine.com |
3 | 5 | $29M | Series A Mar 2012 |
| ReDent Nova redentnova.com |
3 | 4 | $8.6M | Seed Jul 2006 |
| Endoron Medical endoronmedical.com |
2 | 3 | $25M | Series A Jul 2024 |
| MetaCure metacure.com |
1 | 1 | $20M | Series B Apr 2009 |
| Oxitone oxitone.com |
1 | 1 | $3M | Seed Sep 2014 |
| Lungtek lungtek.com |
1 | 1 | — | Seed Jul 2016 |
| Date | Investor | Company | Stage | Round size |
|---|---|---|---|---|
| Jul 2024 | European Union | Endoron Medical | Series A | $10M |
| Jul 2024 | Sofinnova PartnersLED | Endoron Medical | Series A | $10M |
| Jul 2022 | MedtronicLED | CathWorks | Series E+ | $75M |
| Dec 2021 | Sofinnova PartnersLED | Endoron Medical | Seed | $5M |
| Jul 2020 | BioventusLED | CartiHeal | Series D | $15M |
| Feb 2019 | DeerfieldLED | CathWorks | Series C | $30M |
| Jan 2018 | Peregrine Ventures | CartiHeal | Series C | $2.5M |
| Jan 2018 | Bioventus | CartiHeal | Series C | $2.5M |
| Jan 2018 | Johnson & Johnson Innovation – JJDCLED | CartiHeal | Series C | $2.5M |
| Jan 2018 | aMoonLED | CartiHeal | Series C | $2.5M |
| Jan 2018 | Elron Ventures | CartiHeal | Series C | $2.5M |
| Oct 2017 | Quark VentureLED | CathWorks | Series B | $15.8M |
| Oct 2017 | Planven Investments | CathWorks | Series B | $15.8M |
| Oct 2017 | GF Securities | CathWorks | Series B | $15.8M |
| Oct 2017 | Pontifax | CathWorks | Series B | $15.8M |
| Oct 2017 | Corundum Open Innovation | CathWorks | Series B | $15.8M |
| Oct 2017 | BioStar Capital | CathWorks | Series B | $15.8M |
| Oct 2017 | TriventuresLED | CathWorks | Series B | $15.8M |
| Sep 2017 | Docor | Colospan | Series A | $8M |
| Sep 2017 | Clal Biotechnology Industries | Colospan | Series A | $8M |
Life Sciences investors in other cities
Other markets in Kfar Saba